The platelet inhibiting effect of a clopidogrel bolus dose in patients on long-term acetylsalicylic acid treatment
Authors:
- Ulrica AlströmUAUlrica Alström
- Hans TydénHTHans Tydén
- Jonas OldgrenJOJonas Oldgren
- Agneta SiegbahnASAgneta Siegbahn
- Elisabeth StåhleESElisabeth Ståhle
- 31 December 2007
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 120 (3) , 353-359
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Addition of clopidogrel to aspirin in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trialThe Lancet, 2005
- Inflammation, Atherosclerosis, and Coronary Artery DiseaseNew England Journal of Medicine, 2005
- Addition of Clopidogrel to Aspirin and Fibrinolytic Therapy for Myocardial Infarction with ST-Segment ElevationNew England Journal of Medicine, 2005
- Guidelines for Percutaneous Coronary InterventionsEuropean Heart Journal, 2005
- Antithrombotic Therapy for Coronary Artery DiseaseChest, 2004
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment ElevationNew England Journal of Medicine, 2001
- Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE studyThe Lancet, 2001
- Identification of the platelet ADP receptor targeted by antithrombotic drugsNature, 2001
- A Randomized Comparison of Clopidogrel and Aspirin Versus Ticlopidine and Aspirin After the Placement of Coronary-Artery StentsCirculation, 2000